• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders.慢性阻塞性肺疾病急性加重期的抗菌药物——对医嘱执行前后至下次加重期时间的分析
Can J Infect Dis. 2003 Sep;14(5):254-9. doi: 10.1155/2003/392617.
2
Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease.改善慢性阻塞性肺疾病急性加重住院患者护理的医嘱集
Ann Am Thorac Soc. 2016 Jun;13(6):811-5. doi: 10.1513/AnnalsATS.201507-466OC.
3
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病急性加重期的抗生素
Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257.
4
Impact of antibiotic choice on readmission in adults experiencing an acute COPD exacerbation.抗生素选择对成人急性 COPD 加重后再入院的影响。
Am J Health Syst Pharm. 2021 Feb 19;78(Suppl 1):S26-S32. doi: 10.1093/ajhp/zxaa317.
5
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
6
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.C 反应蛋白即时检测用于安全减少慢性阻塞性肺疾病急性加重期抗生素使用的研究:PACE RCT。
Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150.
7
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
8
Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.多西环素治疗门诊治疗的 COPD 急性加重:一项随机双盲安慰剂对照试验。
Lancet Respir Med. 2017 Jun;5(6):492-499. doi: 10.1016/S2213-2600(17)30165-0. Epub 2017 May 5.
9
Effectiveness of a standardized electronic admission order set for acute exacerbation of chronic obstructive pulmonary disease.标准化电子入院医嘱集对慢性阻塞性肺疾病急性加重期的疗效。
BMC Pulm Med. 2018 May 30;18(1):93. doi: 10.1186/s12890-018-0657-x.
10
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)的预防性抗生素治疗
Cochrane Database Syst Rev. 2013 Nov 28(11):CD009764. doi: 10.1002/14651858.CD009764.pub2.

引用本文的文献

1
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病加重期的抗生素
Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD010257. doi: 10.1002/14651858.CD010257.pub2.

本文引用的文献

1
Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials.老年抗菌药物与新型抗菌药物治疗慢性支气管炎门诊急性加重的临床结局
Ann Pharmacother. 2002 Jun;36(6):975-80. doi: 10.1345/aph.1A315.
2
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.吉米沙星与克拉霉素治疗慢性支气管炎急性加重期的比较及长期临床疗效
Clin Ther. 2002 Apr;24(4):639-52. doi: 10.1016/s0149-2918(02)85139-6.
3
Community-acquired lower respiratory tract infections: etiology and treatment.
Chest. 2001 Dec;120(6):2021-34. doi: 10.1378/chest.120.6.2021.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.慢性阻塞性肺疾病诊断、管理和预防全球策略。美国国立心肺血液研究所/世界卫生组织慢性阻塞性肺疾病全球倡议(GOLD)研讨会总结。
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039.
5
Management of acute exacerbations of COPD: a summary and appraisal of published evidence.慢性阻塞性肺疾病急性加重的管理:已发表证据的总结与评估
Chest. 2001 Apr;119(4):1190-209. doi: 10.1378/chest.119.4.1190.
6
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.慢性阻塞性肺疾病急性加重的管理:已发表证据的总结与评估
Ann Intern Med. 2001 Apr 3;134(7):600-20. doi: 10.7326/0003-4819-134-7-200104030-00016.
7
Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期管理的循证依据
Ann Intern Med. 2001 Apr 3;134(7):595-9. doi: 10.7326/0003-4819-134-7-200104030-00015.
8
Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study.慢性支气管炎急性加重期的抗生素治疗与疾病基线严重程度:对一项安慰剂对照随机研究先前发表数据的重新评估
Pulm Pharmacol Ther. 2001;14(2):149-55. doi: 10.1006/pupt.2001.0289.
9
Infectious etiology of acute exacerbations of chronic bronchitis.慢性支气管炎急性加重的感染性病因
Chest. 2000 May;117(5 Suppl 2):380S-5S. doi: 10.1378/chest.117.5_suppl_2.380s.
10
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者病情加重的时间进程及恢复情况
Am J Respir Crit Care Med. 2000 May;161(5):1608-13. doi: 10.1164/ajrccm.161.5.9908022.

慢性阻塞性肺疾病急性加重期的抗菌药物——对医嘱执行前后至下次加重期时间的分析

Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders.

作者信息

Goddard Rob D, McNeil Shelly A, Slayter Kathryn L, McIvor R Andrew

机构信息

Department of Pharmacy, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia.

出版信息

Can J Infect Dis. 2003 Sep;14(5):254-9. doi: 10.1155/2003/392617.

DOI:10.1155/2003/392617
PMID:18159466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2094950/
Abstract

OBJECTIVE

To compare the mean time to next exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) before and after the implementation of standing orders.

SETTING

Tertiary care hospital, Halifax, Nova Scotia, Canada.

POPULATION STUDIED

The records of 150 patients were analyzed, 76 were in the preimplementation group, 74 in the postimplementation group.

INTERVENTION

The management and outcomes of patients admitted with an acute exacerbation of COPD before and after the implementation of standing orders were compared.

DESIGN

A retrospective chart review.

MAIN RESULTS

THERE WAS NO DIFFERENCE IN THE MEAN TIME TO NEXT EXACERBATION BETWEEN TREATMENT GROUPS (PREIMPLEMENTATION GROUP: 310 days, postimplementation group: 289 days, P=0.53). Antibiotics were used in 90% of the cases (preimplementation group: 87%, postimplementation group: 93%). The postimplementation group had a 20% increase in the use of first-line agents over the preimplementation group. Overall, first-line agents represented only 37% of the antibiotic courses.

CONCLUSIONS

The implementation of standing orders encouraged the use of first-line agents but did not influence subsequent symptom resolution, length of hospital stay, or the infection-free interval in patients with acute exacerbations of COPD.

摘要

目的

比较慢性阻塞性肺疾病(COPD)急性加重患者在实施预立医嘱前后至下次加重的平均时间。

地点

加拿大新斯科舍省哈利法克斯的三级护理医院。

研究人群

分析了150例患者的记录,实施前组76例,实施后组74例。

干预措施

比较了COPD急性加重患者在实施预立医嘱前后的管理情况及结局。

设计

回顾性病历审查。

主要结果

治疗组之间至下次加重的平均时间无差异(实施前组:310天,实施后组:289天,P = 0.53)。90%的病例使用了抗生素(实施前组:87%,实施后组:93%)。与实施前组相比,实施后组一线药物的使用增加了20%。总体而言,一线药物仅占抗生素疗程的37%。

结论

预立医嘱的实施鼓励了一线药物的使用,但对COPD急性加重患者随后的症状缓解、住院时间或无感染间隔没有影响。